163 related articles for article (PubMed ID: 12209647)
21. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions.
Yang L; Mosmann T
Eur J Immunol; 2004 Jun; 34(6):1617-26. PubMed ID: 15162431
[TBL] [Abstract][Full Text] [Related]
23. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
24. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo.
Levin D; Constant S; Pasqualini T; Flavell R; Bottomly K
J Immunol; 1993 Dec; 151(12):6742-50. PubMed ID: 7903097
[TBL] [Abstract][Full Text] [Related]
25. The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo.
DiMolfetto L; Neal HA; Wu A; Reilly C; Lo D
Cell Immunol; 1998 Jan; 183(1):70-9. PubMed ID: 9578721
[TBL] [Abstract][Full Text] [Related]
26. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
27. In vitro skewing of TCR transgenic CD4+ T cells from interleukin-2 deficient mice towards Th1 and Th2 in the absence of exogenous interleukin-2.
Santner-Nanan B; Wagner S; Wolf M; Kneitz B; Hünig T; Schimpl A
Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):17-25. PubMed ID: 9831181
[TBL] [Abstract][Full Text] [Related]
28. Ethanol consumption modifies dendritic cell antigen presentation in mice.
Heinz R; Waltenbaugh C
Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
[TBL] [Abstract][Full Text] [Related]
29. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
30. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
31. Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production.
Bocek P; Foucras G; Paul WE
J Exp Med; 2004 Jun; 199(12):1619-30. PubMed ID: 15210741
[TBL] [Abstract][Full Text] [Related]
32. Priming antiviral cytotoxic T lymphocytes: requirement for CD4+ cells is dependent on the antigen presenting cell in vivo.
Ciavarra RP; Tedeschi B
Cell Immunol; 1994 Aug; 157(1):132-43. PubMed ID: 7913664
[TBL] [Abstract][Full Text] [Related]
33. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
[TBL] [Abstract][Full Text] [Related]
34. Endocrine disruptors that deplete glutathione levels in APC promote Th2 polarization in mice leading to the exacerbation of airway inflammation.
Kato T; Tada-Oikawa S; Takahashi K; Saito K; Wang L; Nishio A; Hakamada-Taguchi R; Kawanishi S; Kuribayashi K
Eur J Immunol; 2006 May; 36(5):1199-209. PubMed ID: 16598818
[TBL] [Abstract][Full Text] [Related]
35. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387
[TBL] [Abstract][Full Text] [Related]
36. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors.
Löhning M; Hegazy AN; Pinschewer DD; Busse D; Lang KS; Höfer T; Radbruch A; Zinkernagel RM; Hengartner H
J Exp Med; 2008 Jan; 205(1):53-61. PubMed ID: 18195073
[TBL] [Abstract][Full Text] [Related]
37. The expression of CD45RB on antigen-responsive CD4+ lymphocytes: mouse strain polymorphism and different responses to distinct antigens.
Gahring LC; Ernst DN; Romball CG; Thoman ML; Torbett BE; Hobbs M; Weigle WO
Cell Immunol; 1993 May; 148(2):269-82. PubMed ID: 7684327
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
39. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
Serre K; Giraudo L; Siret C; Leserman L; Machy P
Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
[TBL] [Abstract][Full Text] [Related]
40. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
Tamura T; Ariga H; Kinashi T; Uehara S; Kikuchi T; Nakada M; Tokunaga T; Xu W; Kariyone A; Saito T; Kitamura T; Maxwell G; Takaki S; Takatsu K
Int Immunol; 2004 Dec; 16(12):1691-9. PubMed ID: 15477229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
